MEDICAL IP vs TeraRecon (2026)
One of these produces measurements and the other runs algorithms from many sources, including its own. MEDICAL IP does segmentation and quantification, one capability underneath a broad portfolio across modalities and body regions, with regulatory clearances in several jurisdictions. TeraRecon is vendor neutral advanced visualization with an AI Framework that runs its own algorithms, third party algorithms and a site's in house models through one PACS integration, and physicians accept or reject each result before it reaches the report. They fit together rather than compete. The diligence point is that a platform hosting third party algorithms does not show their regulatory status, so a hospital checks each one, including any segmentation the rest is derived from.
- Segmentation and quantification is one capability underneath a broad portfolio, evidenced across modalities and body regions.
- A regulatory portfolio across several jurisdictions, built over a decade.
- The cleared scope constrains what the outputs may be used for, which does some of the work vendor disclosure would otherwise do.
- Vendor neutral visualization is the base: TeraRecon AV reads CT, MR and other modalities in 2D, 3D and 4D, independent of scanner or archive vendor, at more than 2,000 hospitals by its own count.
- One integration for many models: the AI Framework runs TeraRecon's own algorithms, third party algorithms and a site's in house models through one PACS connection, with physicians accepting or rejecting results before they reach the report.
- Conformance published: indications for use and IHE, DICOM and HL7 conformance statements are public, and ISO 27001:2022 certification was announced in 2023.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. MEDICAL IP and TeraRecon are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | MEDICAL IP | TeraRecon |
|---|---|---|
| Primary category | Radiology & Imaging AI | Radiology & Imaging AI |
| Founded | 2015 | Not recorded |
| Headquarters | Seoul, South Korea | Fremont, California |
| Website | medicalip.com | terarecon.com |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
MEDICAL IP
-
Clinical evidence
A retrospective study published in PLOS ONE validated MEDIP PRO's ability to segment orbital structures on CT imaging to assess Thyroid Eye Disease (TED) activity.
Source
TeraRecon
-
Product / capability
TeraRecon released TeraRecon Neuro, a new software package designed to assist clinicians in diagnosing and treating neurovascular emergencies such as stroke.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
MEDICAL IP builds AI segmentation and quantification software for medical imaging. MEDIP PRO converts CT and MRI into segmented 3D anatomical models for planning and 3D printing; DeepCatch measures muscle, visceral fat and bone density on CT, and the DeepCatch X modules take measurements from a single chest X-ray (aorta, heart, torso, tuberculosis and emphysema); DeepFore predicts liver cancer occurrence and DeepFore Recur its recurrence; TiSepX performs lung volumetry.
Source: AI Health Index, August 2026
TeraRecon, a ConcertAI company, sells advanced visualization and AI workflow software for radiology and cardiology. TeraRecon AV (registered as Intuition outside the US) is vendor neutral 2D, 3D and 4D visualization, measurement and reporting across CT, MR and other modalities, with modules for cardiac, structural heart, perfusion and neuro work.
Source: AI Health Index, August 2026
Questions buyers ask
How do MEDICAL IP and TeraRecon work with the EHR?
MEDICAL IP works on standard imaging and names its users.
TeraRecon's regulatory page links IHE integration statements, a DICOM conformance statement and an HL7 conformance statement for its connector. The AI Framework shares results with the site's reporting system by DICOM and HL7 and integrates with PACS once for many algorithms. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How are MEDICAL IP and TeraRecon priced and sold?
In MEDICAL IP's case, the portfolio makes the gap wider: MEDIP PRO, the individual DeepCatch X modules, DeepFore, the ANATDEL 3D printing service and the anatomy education products are different propositions with different natural units, and nothing indicates whether they are licensed separately or bundled, or priced per study, per seat or per site.
The site shows how the offer is structured: TeraRecon AV (Intuition) for advanced visualization, TR Neuro, DETECT and the AI Framework, sold through a demo request and delivered installed or as a cloud service with professional services for integration. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
What evidence is published for MEDICAL IP and TeraRecon?
With MEDICAL IP, a randomized study compared virtual anatomy dissection with cadaver dissection for the education products, and clinical results with patient specific 3D kidney models in robotic partial nephrectomy have been published. MEDICAL IP is a Seoul National University Hospital spin off, and much of the clinical work comes from that institution.
TeraRecon says more than 2,000 hospitals use its imaging software, reports over 20 years in advanced visualization and a five year customer net promoter score, and has been named a KLAS Category Leader for advanced visualization. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Radiology & Imaging AI page.
MEDICAL IP's record has not yet been reviewed on this site, so its side of this page rests on the build record; it publishes no hosting, residency or data handling terms. TeraRecon publishes no clearance numbers or performance figures for its own AI devices. Neither publishes a subgroup performance analysis or pricing.